Clinical Trial Update: Increasing Measles Vaccination Coverage Through Supplementation With an SQ-LNS Incentive in Children Aged 6-23 Months [NA]

View source ↗

Summary

A completed trial assessing whether supplementation with SQ-LNS incentives can boost measles vaccination coverage in children aged 6-23 months.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Measles

Drugs mentioned

• SQ-LNS (small-quantity lipid-based nutrient supplement)

Snippet

Sponsor: Alliance for International Medical Action | Conditions: Immunization Coverage, Vaccination | NA | Status: COMPLETED